Middle-Age Obesity Linked to Changes in Brain Neurons, Japanese Study Finds
Recent research from Japan has uncovered a fascinating link between middle-age obesity and changes in brain neuron shape, with potential implications for humans. The study focused on the impact of a protein called melanocortin-4 (MC4R) on obesity in rats, revealing that MC4R accumulates in primary cilia, affecting metabolism and fat-burning ability. The findings offer valuable insights into the complex relationship between neuronal shape and obesity, potentially paving the way for innovative approaches to weight management and metabolic health.
Estrogen’s protective role against fatty liver disease revealed in new study
New research from Karolinska Institutet reveals how estrogen protects against metabolic dysfunction-associated steatotic liver disease (MASLD), a form of fatty liver disease that has surged during the global obesity epidemic. The study sheds light on a potential future treatment for fatty liver disease and liver cancer, offering promising insights into addressing the rising prevalence of MASLD and its associated health risks.
FDA approves Novo Nordisk’s weight loss drug Wegovy for reducing cardiovascular risk
The FDA has approved Novo Nordisk’s weight loss drug, Wegovy, for reducing the risk of serious cardiovascular complications in adults with obesity and heart disease. This could expand insurance coverage for the drug, addressing a major barrier to patient access. Wegovy has been shown to reduce the overall risk of heart attack, stroke, and cardiovascular-related death by 20%, marking a significant milestone in public health for adults with obesity and heart disease.
Scrutiny over Restrictions on Weight-Loss Drugs Reveals Disparities in Obesity Care Coverage
Healthcare organizations and insurers are facing scrutiny over the restrictions placed on weight-loss drugs, shedding light on the disparities in obesity care coverage. The rise of highly effective weight-loss medications has brought attention to the unequal treatment of obesity within health plans, sparking initiatives like the EveryBODY campaign to advocate for comprehensive coverage. The debate surrounding coverage for obesity care has also been influenced by pharmaceutical companies, with some advocating for broader coverage to expand their customer base. Zeke Emanuel, a medical ethicist, highlighted the disparities in obesity care coverage as a reflection of deep-seated societal biases, emphasizing the need for a more equitable approach to obesity care coverage.
Obesity Surpasses Undernutrition as Most Common Form of Malnutrition Worldwide
Obesity has become the most common form of malnutrition, affecting over one billion people globally. The alarming rise in childhood obesity and the significant health risks associated with excess weight are highlighted in a recent study published in The Lancet. The research underscores the global challenge in addressing the escalating obesity crisis, emphasizing the concerning trajectory of this prevalent form of malnutrition.
French Campaign Aims to Combat Fatphobia and Discrimination Against Individuals with Obesity
French Obese National Associations Collective (CNAO) and BETC Paris launch ‘The Weight of Words’ campaign to combat fatphobia and raise awareness about discrimination faced by individuals with obesity. With nearly half of the adult population in France categorized as overweight or obese, the initiative aims to challenge societal perceptions and promote empathy towards individuals with larger bodies.
Survey Reveals American Perceptions of Weight-Loss Drugs and Their Impact on Obesity
A recent Pew Research Center survey reveals Americans’ perceptions of weight-loss drugs like Ozempic and Wegovy, with 53% believing they are viable options for individuals with obesity. Despite high demand and supply shortages, only 16% of respondents expect these drugs to significantly reduce obesity in the U.S.
Prevalence of Nonprescribed Weight-Loss Product Consumption Among Adolescents: 5 Key Takeaways
A recent systematic review and meta-analysis published in JAMA uncovered 5 key takeaways about the prevalence of nonprescribed weight-loss product consumption among adolescents, shedding light on this concerning trend.
UK’s Efforts to Combat Obesity Hit Roadblock as Firms Increase Calorie Content in Food Products
Government’s efforts to combat obesity crisis face a setback as firms increase calorie content in food products, defying calls for reduction. Men and women consuming excess calories, with significant increases in calorie consumption from various product types. Report highlights challenges in reducing calorie intake and underscores the need for more robust strategies and collaboration with food industry stakeholders.
Study Explores Relationship Between Kimchi Consumption and Obesity in South Korea
In a recent study published in the journal BMJ Open, researchers explored the relationship between kimchi consumption and obesity in South Korea. Obesity is associated with nutritional, environmental, and lifestyle factors and is a significant risk factor for diabetes, chronic…